521 related articles for article (PubMed ID: 20569697)
1. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.
Pang R; Law WL; Chu AC; Poon JT; Lam CS; Chow AK; Ng L; Cheung LW; Lan XR; Lan HY; Tan VP; Yau TC; Poon RT; Wong BC
Cell Stem Cell; 2010 Jun; 6(6):603-15. PubMed ID: 20569697
[TBL] [Abstract][Full Text] [Related]
2. Metastatic cancer stem cells: an opportunity for improving cancer treatment?
Diehn M; Majeti R
Cell Stem Cell; 2010 Jun; 6(6):502-3. PubMed ID: 20569685
[No Abstract] [Full Text] [Related]
3. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
4. Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis.
Cheung AH; Iyer DN; Lam CS; Ng L; Wong SKM; Lee HS; Wan T; Man J; Chow AKM; Poon RT; Pang R; Law WL
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545226
[TBL] [Abstract][Full Text] [Related]
5. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
6. Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26(+) cancer stem cells in colorectal carcinoma.
Chow AK; Cheng NS; Lam CS; Ng L; Wong SK; Wan TM; Man JH; Cheung AH; Yau TC; Poon JT; Law WL; Pang RW
Mol Cancer; 2015 Apr; 14():80. PubMed ID: 25884645
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells.
Yamazaki H; Naito M; Ghani FI; Dang NH; Iwata S; Morimoto C
Biochem Biophys Res Commun; 2012 Mar; 419(3):529-36. PubMed ID: 22369943
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
[TBL] [Abstract][Full Text] [Related]
9. CD26 a cancer stem cell marker and therapeutic target.
Davies S; Beckenkamp A; Buffon A
Biomed Pharmacother; 2015 Apr; 71():135-8. PubMed ID: 25960228
[TBL] [Abstract][Full Text] [Related]
10. Primary cultures of human colon cancer as a model to study cancer stem cells.
Koshkin S; Danilova A; Raskin G; Petrov N; Bajenova O; O'Brien SJ; Tomilin A; Tolkunova E
Tumour Biol; 2016 Sep; 37(9):12833-12842. PubMed ID: 27449036
[TBL] [Abstract][Full Text] [Related]
11. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
[TBL] [Abstract][Full Text] [Related]
12. CD26 Induces Colorectal Cancer Angiogenesis and Metastasis through CAV1/MMP1 Signaling.
Ng L; Wong SK; Huang Z; Lam CS; Chow AK; Foo DC; Lo OS; Pang RW; Law WL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163100
[TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
14. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential.
Gao W; Chen L; Ma Z; Du Z; Zhao Z; Hu Z; Li Q
Gastroenterology; 2013 Sep; 145(3):636-46.e5. PubMed ID: 23747337
[TBL] [Abstract][Full Text] [Related]
15. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment.
Yang HZ; Ma Y; Zhou Y; Xu LM; Chen XJ; Ding WB; Zou HB
Cancer Lett; 2015 May; 361(1):128-36. PubMed ID: 25749420
[TBL] [Abstract][Full Text] [Related]
16. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer.
Min J; Liu L; Li X; Jiang J; Wang J; Zhang B; Cao D; Yu D; Tao D; Hu J; Gong J; Xie D
Sci Rep; 2015 Nov; 5():16578. PubMed ID: 26564738
[TBL] [Abstract][Full Text] [Related]
17. [A comparative analysis of colorectal carcinoma cell lines that differ in metastatic potential].
Davydov-Sinitsyn AP; Bazhenova OV; Liskovykh MA; Ponomartsev SV; Chechik LL; Tomilin AN; Tolkunova EN
Tsitologiia; 2013; 55(6):379-87. PubMed ID: 25509104
[TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M
Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206
[TBL] [Abstract][Full Text] [Related]
19. Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.
Jao TM; Tsai MH; Lio HY; Weng WT; Chen CC; Tzeng ST; Chang CY; Lai YC; Yen SJ; Yu SL; Yang YC
Int J Cancer; 2014 Dec; 135(11):2593-603. PubMed ID: 24740680
[TBL] [Abstract][Full Text] [Related]
20. Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note.
James MI; Howells LM; Karmokar A; Higgins JA; Greaves P; Cai H; Dennison A; Metcalfe M; Garcea G; Lloyd DM; Berry DP; Steward WP; Brown K
PLoS One; 2015; 10(2):e0117776. PubMed ID: 25658706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]